International Trial for Pediatric Hepatic Tumours
Phase 3
- Conditions
- <p>Hepatoblastoma, Hepatocellular carcinoma</p>Livertumour10019815
- Registration Number
- NL-OMON25549
- Lead Sponsor
- niversity of Birmingham
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Other
- Sex
- Not specified
- Target Recruitment
- 450
Inclusion Criteria
|
Bij registratie in onderzoek: |
Exclusion Criteria
|
- In het verleden of op dit moment behandeld met chemotherapeutische middelen. |
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Depends on the subgroup; EFS, FFS, OS, toxicity, chemo-related cardiac-, nephro- and oto-toxicity, response, resectability, hearing loss</p><br>
- Secondary Outcome Measures
Name Time Method <p>Depends on the subgroup; EFS, FFS, OS, toxicity, chemo-related cardiac-, nephro- and oto-toxicity, response, resectability, hearing loss</p><br>